Insight Molecular Diagnostics Inc. Increase (Decrease) in Assets Held-for-sale
Insight Molecular Diagnostics Inc. (IMDX) reported Increase (Decrease) in Assets Held-for-sale of $139.00 thousand for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-11-09.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAssetsHeldForSale · last filed 2023-11-09
- Insight Molecular Diagnostics Inc. increase (decrease) in assets held-for-sale for the quarter ending 2023-09-30 was $330.00K.
- Insight Molecular Diagnostics Inc. increase (decrease) in assets held-for-sale for the quarter ending 2023-06-30 was $230.00K.
- Insight Molecular Diagnostics Inc. increase (decrease) in assets held-for-sale for the quarter ending 2023-03-31 was -$421.00K.
| Period end | Increase (Decrease) in Assets Held-for-sale 3 month | Increase (Decrease) in Assets Held-for-sale 6 month | Increase (Decrease) in Assets Held-for-sale 9 month |
|---|---|---|---|
| 2023-09-30 | $330.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $560.00K derived: sum of 2 quarters · filed 2023-11-09 | $139.00K 10-Q · filed 2023-11-09 |
| 2023-06-30 | $230.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | -$191.00K 10-Q · filed 2023-08-10 | |
| 2023-03-31 | -$421.00K 10-Q · filed 2023-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |